Condition
    Moderate Evidence
    Effectiveness 3/5

    Curcumin for Knee Pain

    Curcumin reduces knee osteoarthritis pain in short trials at roughly the level of ibuprofen, without the gastric risk — but it does not change the joint.

    Overview

    Curcumin reduces knee osteoarthritis pain in short trials at roughly the level of ibuprofen, without the gastric risk — but it does not change the joint.

    Verdict

    Mixed evidence

    A reasonable option for knee osteoarthritis pain if NSAIDs are unsuitable. Use a bioavailability-enhanced formulation and treat it as symptom relief.

    How It Works

    Curcumin inhibits NF-kB signalling and downstream COX-2, IL-1beta and TNF-alpha production in synovial tissue, reducing the low-grade inflammation that drives osteoarthritis pain and effusion.

    Dosing & Protocol

    Typical dose

    Recommended dose
    500 mg twice daily bioavailable curcuminoids, up to 1500 mg/day (knee OA trials ran 6-16 weeks)
    Expected timeframe
    4-8 weeks for first change, up to 12 weeks for full effect

    Protocol

    dose
    500 mg twice daily curcuminoids
    form
    Phytosome, micellar or piperine-enhanced curcumin
    steps
    Confirm the diagnosis — knee pain from meniscal tears, gout or inflammatory arthritis needs different treatment,Start 500 mg daily with food for a week, then 500 mg twice daily,Run quadriceps and hip strengthening in parallel; exercise is the single best-evidenced knee OA treatment,Log a 0-10 pain score, stair difficulty and weekly NSAID use,Reassess at 12 weeks and stop if unchanged
    timing
    With fat-containing meals
    duration
    12 weeks

    Evidence

    What the studies say

    Multiple randomised trials and several meta-analyses report clinically meaningful reductions in WOMAC pain and function scores versus placebo over 4-12 weeks, with one head-to-head trial finding curcuminoids non-inferior to ibuprofen 1200mg daily and better tolerated gastrointestinally. Limitations are real: most trials are small, short, and run in India or Iran with high heterogeneity in formulation, and no study demonstrates structural benefit on imaging. Rating of 3 reflects consistent symptom data with weak long-term and structural evidence.

    Impact of Supplementation with Curcuminoids on Systemic Inflammation in Patients with Knee Osteoarthritis: Findings from a Randomized Double-Blind Placebo-Controlled Trial

    Score: 5/10
    2015
    rct
    n=40

    Rahimnia AR, et al

    Significant improvement in clinical symptoms of OA in curcuminoid-treated subjects cannot be attributed to the systemic anti-inflammatory effects of these phytochemicals.

    View source

    Safety

    Caveats

    Mixed evidence: several positive trials are small and industry-funded, and formulations are not interchangeable. Does not slow cartilage loss. Bleeding risk with anticoagulants, antiplatelets and NSAIDs; stop 2 weeks before knee surgery or injection procedures. Avoid in gallstone disease. Rare hepatotoxicity. Avoid therapeutic doses in pregnancy.

    Less likely to help if

    Bone-on-bone advanced OA, mechanical derangement such as a locking meniscus, and users of unenhanced turmeric.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.